← Oncology Approval Tracker

FDA DECISION ·

Jylamvo

methotrexate oral solution · Shorla Oncology

FDA approvalNew or expanded indicationAcute lymphoblastic leukemia
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

Pediatric patients with acute lymphoblastic leukemia, as part of a combination chemotherapy maintenance regimen.

LAMPGEN ANALYSIS

Why it matters

The oral methotrexate solution gained an ALL maintenance indication for children.

What research teams should watch

Use clear weekly-dose instructions and verify solution concentration and volume to prevent dosing errors.

PRIMARY RECORDS

Sources